These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 30446928)

  • 21. Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.
    Kopylov U; Papamichael K; Katsanos K; Waterman M; Bar-Gil Shitrit A; Boysen T; Portela F; Peixoto A; Szilagyi A; Silva M; Maconi G; Har-Noy O; Bossuyt P; Mantzaris G; Barreiro de Acosta M; Chaparro M; Christodoulou DK; Eliakim R; Rahier JF; Magro F; Drobne D; Ferrante M; Sonnenberg E; Siegmund B; Muls V; Thurm T; Yanai H; Dotan I; Raine T; Levin A; Israeli E; Ghalim F; Carbonnel F; Vermeire S; Ben-Horin S; Roblin X
    Inflamm Bowel Dis; 2017 Sep; 23(9):1605-1613. PubMed ID: 28590343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience.
    Halpin SJ; Hamlin PJ; Greer DP; Warren L; Ford AC
    World J Gastroenterol; 2013 Feb; 19(7):1091-7. PubMed ID: 23467174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis.
    Choy MC; Seah D; Faleck DM; Shah SC; Chao CY; An YK; Radford-Smith G; Bessissow T; Dubinsky MC; Ford AC; Churilov L; Yeomans ND; De Cruz PP
    Inflamm Bowel Dis; 2019 Jun; 25(7):1169-1186. PubMed ID: 30605549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inpatient infliximab is ineffective at preventing colectomy for steroid refractory extensive colitis.
    Andrew RE; Lauria A; Puleo FJ; Berg A; Stewart DB
    J Surg Res; 2017 Nov; 219():18-24. PubMed ID: 29078879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensified Infliximab Induction is Associated with Improved Response and Decreased Colectomy in Steroid-Refractory Paediatric Ulcerative Colitis.
    Church PC; Ho S; Sharma A; Tomalty D; Frost K; Muise A; Walters TD; Griffiths AM
    J Crohns Colitis; 2019 Aug; 13(8):982-989. PubMed ID: 30715240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).
    Fernández-Salazar L; Muñoz F; Barrio J; Muñoz C; Pajares R; Rivero M; Prieto V; Legido J; Bouhmidi A; Herranz M; Fernández N; Sánchez-Ocaña R; Joao D; Santos F
    Scand J Gastroenterol; 2016; 51(2):186-95. PubMed ID: 26200929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency, predictors, and consequences of maintenance infliximab therapy intensification in ulcerative colitis.
    Fernández-Salazar L; Barrio J; Muñoz F; Muñoz C; Pajares R; Rivero M; Prieto V; Legido J; Bouhmidi A; Herranz M; González-Redondo G; Fernández N; Santos F; Sánchez-Ocaña R; Joao D;
    Rev Esp Enferm Dig; 2015 Sep; 107(9):527-33. PubMed ID: 26334458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
    Jakobovits SL; Jewell DP; Travis SP
    Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis.
    Murthy SK; Greenberg GR; Croitoru K; Nguyen GC; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2015 Sep; 21(9):2090-6. PubMed ID: 26099066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting the Course of Disease in Hospitalized Patients With Acute Severe Ulcerative Colitis.
    Bernardo S; Fernandes SR; Gonçalves AR; Valente A; Baldaia C; Santos PM; Correia LA
    Inflamm Bowel Dis; 2019 Feb; 25(3):541-546. PubMed ID: 30085135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis.
    Taxonera C; Barreiro-de Acosta M; Calvo M; Saro C; Bastida G; Martín-Arranz MD; Gisbert JP; García-Sánchez V; Marín-Jiménez I; Bermejo F; Chaparro M; Ponferrada Á; Martínez-Montiel MP; Pajares R; de Gracia C; Olivares D; Alba C; Mendoza JL; Fernández-Blanco I
    Dig Dis Sci; 2015 Oct; 60(10):3075-84. PubMed ID: 26044830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter Cohort Study of Infliximab Pharmacokinetics and Therapy Response in Pediatric Acute Severe Ulcerative Colitis.
    Whaley KG; Xiong Y; Karns R; Hyams JS; Kugathasan S; Boyle BM; Walters TD; Kelsen J; LeLeiko N; Shapiro J; Waddell A; Fox S; Bezold R; Bruns S; Widing R; Haberman Y; Collins MH; Mizuno T; Minar P; D'Haens GR; Denson LA; Vinks AA; Rosen MJ
    Clin Gastroenterol Hepatol; 2023 May; 21(5):1338-1347. PubMed ID: 36031093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis.
    Battat R; Hemperly A; Truong S; Whitmire N; Boland BS; Dulai PS; Holmer AK; Nguyen NH; Singh S; Vande Casteele N; Sandborn WJ
    Clin Gastroenterol Hepatol; 2021 Mar; 19(3):511-518.e6. PubMed ID: 32348905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids.
    Narula N; Marshall JK; Colombel JF; Leontiadis GI; Williams JG; Muqtadir Z; Reinisch W
    Am J Gastroenterol; 2016 Apr; 111(4):477-91. PubMed ID: 26856754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy.
    Aloi M; D'Arcangelo G; Capponi M; Nuti F; Vassallo F; Civitelli F; Oliva S; Pagliaro G; Cucchiara S
    Dig Liver Dis; 2015 Jun; 47(6):455-9. PubMed ID: 25733340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Have changing practices in salvage medical options affected colectomy rates in acute severe ulcerative colitis?
    Clark N; MacIsaac M; Little R; Vogrin S; Harrison M; Tiang T; Keck J; Johnston M; Cunningham G; Wright E; Connell W
    Intern Med J; 2023 Dec; 53(12):2231-2239. PubMed ID: 36916208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-Term and Long-Term Outcomes of Infliximab and Tacrolimus Treatment for Moderate to Severe Ulcerative Colitis: Retrospective Observational Study.
    Otsuka T; Ooi M; Tobimatsu K; Wakahara C; Watanabe D; Adachi S; Yasutomi E; Yamairi H; Ku Y; Yoshida M; Hoshi N; Kodama Y
    Kobe J Med Sci; 2018 Dec; 64(4):E140-E148. PubMed ID: 30728340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes of infliximab treatment and predictors of response in 195 patients with ulcerative colitis: a hospital-based cohort study from Korea.
    Seo H; Chang K; Lee SH; Song EM; Kim GU; Seo M; Lee HS; Hwang SW; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yang SK; Park SH
    Scand J Gastroenterol; 2017 Aug; 52(8):857-863. PubMed ID: 28502189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.